Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-03

Clinical Trial Update: Modified Xiao-Feng Powder for Chronic Urticaria [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Modified Xiao-Feng Powder in chronic urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Modified Xiao-Feng Powder

Snippet

Sponsor: Prof. Lin Zhixiu | Conditions: Chronic Urticaria | Phase 2 | Status: UNKNOWN